Can-Fite Reports Preparatory Work For An End Of Phase II Meeting With FDA To Initiate Phase III Study In Liver Cancer Is Ongoing; Patient Enrollment Continues In Two Phase III Studies For Piclidenoson In The Treatment Of Rheumatoid Arthritis And Psoriasis